Table 7 Risk stratification and revascularization strategy and Interventions done for patients with NSTE- ACS
Intervention and Strategy | NSTE-ACS, N = 571 |
|---|---|
TIMI - Risk for NSTE ACS 0–2 (low) 3–4 (intermediate) 5–7 (High) | 11(19.2%) 20(35.1%) 26(45.6%) |
Type of Intervention | Â |
Immediate Invasive (< 2 h), n (%) | 24 (42.1%) |
Early Invasive (< 24 h), n (%) | 16 (28.1%) |
Invasive Strategy (< 72 h), n (%) | 15(26.3%) |
Medical Management, n (%) | 2 (3.5%) |
Coronary angiography - without intervention | 32 (56.1%) |
Coronary angiography + PCI | 12 (21.1%) |
Coronary angiography - referred for CABG | 6 (10.5%) |
Coronary angiography + PCI in 2vessel | 5 (8.8%) |
No angiography - Medical management | 2 (3.5%) |
Eptifibatide Infusion | 2(3.5%) |
DAPT therapy on discharge amongst patients with significant CAD (n = 23) Aspirin + Clopidogrel Aspirin + Ticagrelor Aspirin + Prasugrel Triple therapy with NOAC Triple Therapy with Warfarin | 15 (65.2%) 6 (26.0%) 2 (8.6%) 2 (3.7%) 1 (1.9%) |